Literature DB >> 6021780

Long-term reduction of serum cholesterol levels of patients with atherosclerosis by small doses of neomycin.

P Samuel, C M Holtzman, J Goldstein.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 6021780     DOI: 10.1161/01.cir.35.5.938

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  9 in total

Review 1.  Present understanding of the interaction of drugs and food during absorption.

Authors:  A Krondl
Journal:  Can Med Assoc J       Date:  1970-08-15       Impact factor: 8.262

Review 2.  Hypolipaemic drugs and coronary heart disease.

Authors:  A N Howard
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1975

3.  Fat absorption and metabolism.

Authors:  G Thompson
Journal:  Gastroenterol Jpn       Date:  1984-06

4.  Effect of neomycin on exchangeable pools of cholesterol in the steady state.

Authors:  P Samuel; C H Holtzman; E Meilman; W Perl
Journal:  J Clin Invest       Date:  1968-08       Impact factor: 14.808

5.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15

6.  Effect of neomycin sulphate alone and in combination with D-thyroxine on serum lipoproteins in hypercholesterolaemic subjects.

Authors:  K H Vogelberg; T Koschinsky; H Hein; F A Gries
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

Review 7.  Adverse effects of hypolipidaemic drugs.

Authors:  L C Knodel; R L Talbert
Journal:  Med Toxicol       Date:  1987 Jan-Feb

8.  Effects of neomycin alone and in combination with cholestyramine on serum cholesterol and fecal steroids in hypercholesterolemic subjects.

Authors:  T A Miettinen
Journal:  J Clin Invest       Date:  1979-11       Impact factor: 14.808

9.  Action of neomycin on the intraluminal phase of lipid absorption.

Authors:  G R Thompson; J Barrowman; L Gutierrez; R H Dowling
Journal:  J Clin Invest       Date:  1971-02       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.